Collectively, these findings suggest that Fn can promote CRC proliferation and migration by interfering with a variety of biological processes, such as induction of the epithelial–mesenchymal transition, reprogramming of the tumor microenvironment, expression of oncogenic ncRNAs, and disruption of host DNA. The gene discussed is FN1; the disease is colorectal carcinoma.